 |
Ethyl 4-(3,4-dimethoxyphenyl)-6,7-dimethoxy-2-(1,2,4-triazol-1-ylmethyl)quinoline-3-carboxylate |
|---|---|
| Trade Name | |
| Orphan Indication | Crohn's disease |
| USA Market Approval | USA |
| USA Designation Date | 1998-05-13 00:00:00 |
| Sponsor | Tap Holdings Inc.;2355 Waukegan Road;Deerfield, Illinois, 60015 |
